INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$890K
2,854 sh
Jun 24, 2026
Page 608 of 1717
← PrevNext →
Jun 26, 2026
traded Jun 24, 2026
+2d
SEC Form 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
1,279 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

19
BH
Baker Eric HowardDirector, See Remarks, 10% Owner
STUBStubHub Holdings, Inc.
Option exercise
M$407K
739.3K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

18
HS
Hendricks Dana SChief Financial Officer
PRAPROASSURANCE CORP
Disposition to issuer
D$1.13M
45.4K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

18
GD
Graff Marc D.SVP & Chief Financial Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$57K
126 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

18
BH
Baker Eric HowardDirector, See Remarks, 10% Owner
STUBStubHub Holdings, Inc.
Tax withholding
F$4.78M
415.1K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

18
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$2.62M
67.8K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
WP
Wierbicki PaulDirector, Chief Legal Officer
RSIRush Street Interactive, Inc.
Option exercise
M—
6,926 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

17
HW
Hoge Brett WidneyDirector
NWTGNewton Golf Company, Inc.
Grant or award
A—
63.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
MT
Mackey Brian TChief Executive Officer
CPSHCPS TECHNOLOGIES CORP/DE/
Option exercise
M$29K
10.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Option exercise · 10b5-1 plan
M$379K
8,566 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
KD
Krulik DouglasCAO and Interim CFO
PETSPETMED EXPRESS INC
Grant or award
A—
32.5K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

17
VS
Vellandi Alexander S.Director
NANAStrategic Storage Trust VI, Inc.
Grant or award
A—
2,500 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
HA
Hughes AaronDirector
SSentinelOne, Inc.
Grant or award
A—
14.2K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

17
HJ
Hogan Michael JamesChief Strategy Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$234K
2,800 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

17
MG
Muzzy Stephen GDirector
NANAStrategic Storage Trust VI, Inc.
Grant or award
A—
2,500 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
LR
Lewis Michelle ReneeChief Accounting Officer
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$600K
15.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

16
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$2.82M
11.1K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
6,944 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

16
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$4.06M
16.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
CH
Colson Nathaniel HOfficer EVP, CFO & CRO
MTGMGIC INVESTMENT CORP
Open-market sale · 10b5-1 plan
SELL$542K
20.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

15
GT
Galla Christopher TSVP, GC, and Corp. Secretary
GPCGENUINE PARTS CO
Open-market sale · 10b5-1 plan
SELL$268K
2,333 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$382K
1,240 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$314K
1,004 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
CF
Cobarrubias FabiloaDirector
PRAPROASSURANCE CORP
Disposition to issuer
D$630K
25.2K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
MS
McClain SeanDirector, Chief Executive Officer
ABSIAbsci Corp
Tax withholding
F$603K
59.9K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
FH
Frei Maye HeadDirector
PRAPROASSURANCE CORP
Disposition to issuer
D$782K
31.3K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
SC
Syphax Scott CDirector
PRAPROASSURANCE CORP
Disposition to issuer
D$630K
25.2K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
VC
Van Tuyl ChristopherChief Legal Officer
IMVTImmunovant, Inc.
Option exercise
M$271K
17.8K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$544K
1,750 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$309K
999 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

15
VT
Vance Katisha TerrellDirector
PRAPROASSURANCE CORP
Disposition to issuer
D$854K
34.2K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
AD
Angiolillo Bruce DDirector
PRAPROASSURANCE CORP
Disposition to issuer
D$891K
35.7K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
FD
Francis Robert DavidPres Healthcare Pro. Liability
PRAPROASSURANCE CORP
Disposition to issuer
D$780K
31.2K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
DN
Dishart NoreenExecutive VP/Chief HR Officer
PRAPROASSURANCE CORP
Disposition to issuer
D$682K
27.9K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

15
PS
Pierce StaciDirector
PRAPROASSURANCE CORP
Disposition to issuer
D$266K
10.6K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

14
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.63M
35.2K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

14
SD
Seymour DavidEVP Chief Operating Officer
AALAmerican Airlines Group Inc.
Open-market sale · 10b5-1 plan
SELL$1.02M
56.5K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

14
VE
Venker EricPresident & Immunovant CEO
ROIVRoivant Sciences Ltd.
Open-market sale · 10b5-1 plan
SELL$5.08M
153.8K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

14
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$5.80M
78.9K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence